Scholars@Duke

"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.

Publication ,  Journal Article
Friedman, DR
Published in: Leuk Lymphoma
March 2013
Published version (DOI) Link to item

Duke Scholars

Daphne Ruth Friedman
Author Daphne Ruth Friedman Medicine, Medical Oncology

Published In

Leuk Lymphoma

DOI

10.3109/10428194.2012.727420

EISSN

1029-2403

Publication Date

March 2013

Volume

54

Issue

3

Start / End Page

441 / 442

Location

United States

Related Subject Headings

  • Male
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Immunology
  • Humans
  • Female
  • Antineoplastic Combined Chemotherapy Protocols
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, D. R. (2013). "Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia. Leuk Lymphoma, 54(3), 441–442. https://doi.org/10.3109/10428194.2012.727420
Friedman, Daphne R. “"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.” Leuk Lymphoma 54, no. 3 (March 2013): 441–42. https://doi.org/10.3109/10428194.2012.727420.
Friedman, Daphne R. “"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia.” Leuk Lymphoma, vol. 54, no. 3, Mar. 2013, pp. 441–42. Pubmed, doi:10.3109/10428194.2012.727420.

Published In

Leuk Lymphoma

DOI

10.3109/10428194.2012.727420

EISSN

1029-2403

Publication Date

March 2013

Volume

54

Issue

3

Start / End Page

441 / 442

Location

United States

Related Subject Headings

  • Male
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Immunology
  • Humans
  • Female
  • Antineoplastic Combined Chemotherapy Protocols
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences